Cargando…
Resistant thrombocytopenia in an HIV and hepatitis C patient: treatment response with novel agent eltrombopag
HIV-associated thrombocytopenia is a disease which can be recurrent to standard therapy which includes highly active antiretroviral therapy (HAART) therapy, steroids and immunoglobulin. We report a patient with HIV and hepatitis C who presented with resistant thrombocytopenia. Treatment with Eltromb...
Autores principales: | Vijayakrishnan, Rajakrishnan, Dani, Sourbha, Ramasubramanian, Aparna, Nair, Rekha, Samaha, Tony M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981206/ https://www.ncbi.nlm.nih.gov/pubmed/24765278 http://dx.doi.org/10.4081/cp.2011.e5 |
Ejemplares similares
-
Considerations in the Management of Hepatitis C Virus-related Thrombocytopenia with Eltrombopag
por: Danish, Fazal A., et al.
Publicado: (2010) -
The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
por: Danish, Fazal-i-Akbar, et al.
Publicado: (2013) -
Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
por: Elbedewy, Tamer A, et al.
Publicado: (2019) -
Acute renal failure, thrombocytopenia, and elevated liver enzymes after concurrent abuse of alcohol and cocaine
por: Hosseinnezhad, Alireza, et al.
Publicado: (2011) -
Eltrombopag in long‐term management of pediatric thrombocytopenia
por: Shah, Sanjay J., et al.
Publicado: (2018)